Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
1.73
- 0.04 (-2.26%)
Day High: 1.89
Day Low:  1.66
Volume:    2,264,299
4:00 PM ET on Mar 24, 2017

Delayed at least 20 minutes.